An observational study in Coronavirus, sponsored by Shanghai Public Health Clinical Center. Status unknown at 1 site in China. Per ClinicalTrials.gov, last updated 2020-03-03.
Sponsored by Shanghai Public Health Clinical Center · Observational
There is still no effective antiviral drugs and vaccines against SARS-CoV-2 yet now. This is an obsevational study, the investigators collected the clinical information and clinical outcomes of the COVID-19 patients using anti-2019-nCoV inactivated convalescent plasma.The study is to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of COVID-19 pneumonia.
929 studies on the registry are indexed under Coronavirus Infections; 50 are open to participants now.
This study's planned enrollment of 15 is below the median of 300 across 334 observational studies indexed under Coronavirus Infections.
Browse Coronavirus Infections studies →Shanghai Public Health Clinical Center is the lead sponsor of 37 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Participants received anti-SARS-CoV-2 inactivated convalescent plasma
Exclusion Criteria:
The virological clearance rate of throat swabs, sputum, or lower respiratory tract secretions at day 1
The SARS-CoV-2 nuclei acid was quantified using RT-PCR
Time frame: 1 day after receiving plasma transmission
The virological clearance rate of throat swabs, sputum, or lower respiratory tract secretions at day 3
Time frame: 3 days after receiving plasma transmission
The virological clearance rate of throat swabs, sputum, or lower respiratory tract secretions at day 7
Time frame: 7 days after receiving plasma transmission
Numbers of participants with different Clinical outcomes
Clinical outcomes include death, critical illness, recovery
Time frame: From receiving plasma transmission to 4 weeks
Number of participants with treatment-related adverse events as assessed by CTCAE v5.0
Time frame: 4 weeks after receiving plasma transmission
This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Public Health Clinical Center